HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand

Kachit Choopanya, Don Des Jarlais, Suphak Vanichseni, Philip A. Mock, Dwip Kitayaporn, Udomsak Sangkhum, Boonrawd Prasithiphol, Krit Hiranrus, Frits Van Griensven, Jordan W. Tappero, Timothy D. Mastro

Research output: Contribution to journalArticle

Abstract

Objective: To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand. Methods: During 1995-1996, 1,209 HIV-seronegative IDUs were recruited from Bangkok Metropolitan Administration drug abuse treatment programs to participate in a prospective cohort study. Study visits occurred every 4 months, at which the participants underwent an interview to assess risk behavior and HIV counseling and testing. Eight hundred nine of the IDUs were considered "long-term" participants, who remained in the study through at least the first four scheduled follow-up visits (16 months). Injection risk behavior at each study visit was measured on a four-point scale strongly associated with incident HIV infections in the cohort. Individual regression slopes were used to assess changes in injection risk behavior (risk increase, no change, or risk reduction). Results: Of the 806 long-term study participants, 79% showed declines, 4% showed no change, and 17% showed increases in injection risk behavior. The percentage of participants in the highest-risk category (injecting daily or more frequently and sharing needles and syringes) declined from 42% at baseline to 3% at the final follow-up visit. Being in methadone maintenance treatment was associated with stable low rates of injection risk behavior, while recruitment from the 45-day detoxification treatment was associated with reductions in injection risk behavior. The risk reduction was independent of decline in risk behavior among IDUs in the community at large. Conclusions: Participation in this cohort study was associated with substantial declines in injection risk behavior. This information is important in the evaluation of possible adverse behavioral effects of participation in future preventive HIV vaccine trials including IDUs, particularly in developing country settings.

Original languageEnglish (US)
Pages (from-to)88-95
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume33
Issue number1
DOIs
StatePublished - May 1 2003

Fingerprint

Thailand
Risk Reduction Behavior
Risk-Taking
Drug Users
HIV
Injections
Needle Sharing
Cohort Studies
AIDS Vaccines
Methadone
Developing Countries
HIV Infections
Substance-Related Disorders
HIV-1
Counseling
Therapeutics
Prospective Studies
Interviews

Keywords

  • Bangkok, Thailand
  • HIV
  • Injecting drug users (IDUs)
  • Risk reduction
  • Substance abuse

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. / Choopanya, Kachit; Des Jarlais, Don; Vanichseni, Suphak; Mock, Philip A.; Kitayaporn, Dwip; Sangkhum, Udomsak; Prasithiphol, Boonrawd; Hiranrus, Krit; Van Griensven, Frits; Tappero, Jordan W.; Mastro, Timothy D.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 33, No. 1, 01.05.2003, p. 88-95.

Research output: Contribution to journalArticle

Choopanya, K, Des Jarlais, D, Vanichseni, S, Mock, PA, Kitayaporn, D, Sangkhum, U, Prasithiphol, B, Hiranrus, K, Van Griensven, F, Tappero, JW & Mastro, TD 2003, 'HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand', Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 1, pp. 88-95. https://doi.org/10.1097/00126334-200305010-00013
Choopanya, Kachit ; Des Jarlais, Don ; Vanichseni, Suphak ; Mock, Philip A. ; Kitayaporn, Dwip ; Sangkhum, Udomsak ; Prasithiphol, Boonrawd ; Hiranrus, Krit ; Van Griensven, Frits ; Tappero, Jordan W. ; Mastro, Timothy D. / HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. In: Journal of Acquired Immune Deficiency Syndromes. 2003 ; Vol. 33, No. 1. pp. 88-95.
@article{f6e3aaebcb514345a5a4b24aa2a86984,
title = "HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand",
abstract = "Objective: To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand. Methods: During 1995-1996, 1,209 HIV-seronegative IDUs were recruited from Bangkok Metropolitan Administration drug abuse treatment programs to participate in a prospective cohort study. Study visits occurred every 4 months, at which the participants underwent an interview to assess risk behavior and HIV counseling and testing. Eight hundred nine of the IDUs were considered {"}long-term{"} participants, who remained in the study through at least the first four scheduled follow-up visits (16 months). Injection risk behavior at each study visit was measured on a four-point scale strongly associated with incident HIV infections in the cohort. Individual regression slopes were used to assess changes in injection risk behavior (risk increase, no change, or risk reduction). Results: Of the 806 long-term study participants, 79{\%} showed declines, 4{\%} showed no change, and 17{\%} showed increases in injection risk behavior. The percentage of participants in the highest-risk category (injecting daily or more frequently and sharing needles and syringes) declined from 42{\%} at baseline to 3{\%} at the final follow-up visit. Being in methadone maintenance treatment was associated with stable low rates of injection risk behavior, while recruitment from the 45-day detoxification treatment was associated with reductions in injection risk behavior. The risk reduction was independent of decline in risk behavior among IDUs in the community at large. Conclusions: Participation in this cohort study was associated with substantial declines in injection risk behavior. This information is important in the evaluation of possible adverse behavioral effects of participation in future preventive HIV vaccine trials including IDUs, particularly in developing country settings.",
keywords = "Bangkok, Thailand, HIV, Injecting drug users (IDUs), Risk reduction, Substance abuse",
author = "Kachit Choopanya and {Des Jarlais}, Don and Suphak Vanichseni and Mock, {Philip A.} and Dwip Kitayaporn and Udomsak Sangkhum and Boonrawd Prasithiphol and Krit Hiranrus and {Van Griensven}, Frits and Tappero, {Jordan W.} and Mastro, {Timothy D.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1097/00126334-200305010-00013",
language = "English (US)",
volume = "33",
pages = "88--95",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand

AU - Choopanya, Kachit

AU - Des Jarlais, Don

AU - Vanichseni, Suphak

AU - Mock, Philip A.

AU - Kitayaporn, Dwip

AU - Sangkhum, Udomsak

AU - Prasithiphol, Boonrawd

AU - Hiranrus, Krit

AU - Van Griensven, Frits

AU - Tappero, Jordan W.

AU - Mastro, Timothy D.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Objective: To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand. Methods: During 1995-1996, 1,209 HIV-seronegative IDUs were recruited from Bangkok Metropolitan Administration drug abuse treatment programs to participate in a prospective cohort study. Study visits occurred every 4 months, at which the participants underwent an interview to assess risk behavior and HIV counseling and testing. Eight hundred nine of the IDUs were considered "long-term" participants, who remained in the study through at least the first four scheduled follow-up visits (16 months). Injection risk behavior at each study visit was measured on a four-point scale strongly associated with incident HIV infections in the cohort. Individual regression slopes were used to assess changes in injection risk behavior (risk increase, no change, or risk reduction). Results: Of the 806 long-term study participants, 79% showed declines, 4% showed no change, and 17% showed increases in injection risk behavior. The percentage of participants in the highest-risk category (injecting daily or more frequently and sharing needles and syringes) declined from 42% at baseline to 3% at the final follow-up visit. Being in methadone maintenance treatment was associated with stable low rates of injection risk behavior, while recruitment from the 45-day detoxification treatment was associated with reductions in injection risk behavior. The risk reduction was independent of decline in risk behavior among IDUs in the community at large. Conclusions: Participation in this cohort study was associated with substantial declines in injection risk behavior. This information is important in the evaluation of possible adverse behavioral effects of participation in future preventive HIV vaccine trials including IDUs, particularly in developing country settings.

AB - Objective: To determine changes in risk behavior in relation to study participation among injecting drug users (IDUs) in Bangkok, Thailand. Methods: During 1995-1996, 1,209 HIV-seronegative IDUs were recruited from Bangkok Metropolitan Administration drug abuse treatment programs to participate in a prospective cohort study. Study visits occurred every 4 months, at which the participants underwent an interview to assess risk behavior and HIV counseling and testing. Eight hundred nine of the IDUs were considered "long-term" participants, who remained in the study through at least the first four scheduled follow-up visits (16 months). Injection risk behavior at each study visit was measured on a four-point scale strongly associated with incident HIV infections in the cohort. Individual regression slopes were used to assess changes in injection risk behavior (risk increase, no change, or risk reduction). Results: Of the 806 long-term study participants, 79% showed declines, 4% showed no change, and 17% showed increases in injection risk behavior. The percentage of participants in the highest-risk category (injecting daily or more frequently and sharing needles and syringes) declined from 42% at baseline to 3% at the final follow-up visit. Being in methadone maintenance treatment was associated with stable low rates of injection risk behavior, while recruitment from the 45-day detoxification treatment was associated with reductions in injection risk behavior. The risk reduction was independent of decline in risk behavior among IDUs in the community at large. Conclusions: Participation in this cohort study was associated with substantial declines in injection risk behavior. This information is important in the evaluation of possible adverse behavioral effects of participation in future preventive HIV vaccine trials including IDUs, particularly in developing country settings.

KW - Bangkok, Thailand

KW - HIV

KW - Injecting drug users (IDUs)

KW - Risk reduction

KW - Substance abuse

UR - http://www.scopus.com/inward/record.url?scp=0038372691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038372691&partnerID=8YFLogxK

U2 - 10.1097/00126334-200305010-00013

DO - 10.1097/00126334-200305010-00013

M3 - Article

C2 - 12792360

AN - SCOPUS:0038372691

VL - 33

SP - 88

EP - 95

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -